Human aging is associated with immunosenescence, a process characterized by alterations in numerical and functional features of immune system components. Dendritic cells (DCs) are the main antigen-presenting cells, playing a pivotal role in adaptive and innate immunity. Therefore, we investigated the distribution of human circulating DCs throughout the life, in order to contribute to the knowledge of the physiological background underlying the aging of immune system. Cytofluorimetric analysis of peripheral blood samples by all-aged healthy population showed a significant decrease of circulating DCs and of their two main subsets among age. This reduction was limited to the plasmacytoid cell subtype when young and old subjects were analyzed separately. The analysis of circulating Treg cell number in a cohort of the subjects showed a significant reduction with increasing age and a positive significant correlation to myeloid or plasmacytoid absolute numbers. In conclusion, this work provides a large set of data of normal reference values of peripheral blood dendritic cells in healthy population suitable for comparative clinical studies concerning pathological immune dysfunctions.
Introduction
Aging is associated with the decline of immune system function (immunosenescence), resulting in an increased susceptibility to both bacterial and viral infections, malignancies, autoimmune disorders and reduced response to vaccination (1) .
This has been mainly attributed to changes in the adaptive immunity, as T lymphocytes show a decreased immune response to antigens and cytotoxic activity, altered cytokine secretion pattern, and accumulation of the memory lymphocyte subset, caused by the physiological involution of thymus (2) . Furthermore, B cells display a reduced production of high-affinity antibodies and a general inability to set up long-lasting memory responses (3, 4) . Moreover, recent studies have investigated how human aging affects the innate immune system components, such as macrophages and NK cells (5) . As dendritic cells (DCs) are the most important antigen-presenting cells, playing a pivotal role in T-cell function and in the link between innate and adaptive immunity, we think that the knowledge of their behavior throughout the life is relevant.
DCs in their immature stage are ubiquitously distributed in all peripheral tissues, with a role of sentinels specialized in the uptake and processing of antigen. After capturing it, they migrate to the draining lymph nodes where they present antigens to T cells, generating an antigen-specific response by adaptive immune system. During this migration, DCs lose immature characteristics, such as phagocytic activity, and acquire several phenotypic and functional features typical of mature DCs, including expression at high levels of the major histocompatibility complex and co-stimulatory molecules necessary for the correct antigen presentation and the secretion of cytokines attracting and stimulating T lymphocytes, as well as B cells and NK cells (6) .
Moreover, DCs are also critical mediators of immune tolerance and anergy, depending on the type of antigen they encounter and on the cytokine milieu in which they mature (7) .
Peripheral blood dendritic cells (PBDCs) represent only the 0.1-1% of mononuclear cells (MNCs) and, based on their lineage origins, they can be divided into two major subsets, plasmacytoid DCs (pDCs) and myeloid DCs (mDCs) (8) .
DCs are derived from bone marrow progenitors cells, but pDCs require fms-like tyrosine kinase 3 ligand (Flt3L) and IL-3 for growth and survival (9) , whereas mDCs can originate also from differentiation of circulating monocytes in immature DCs rather than macrophages, in the presence of IL-4 and granulocyte macrophage colony-stimulating factor (10) . Both of them lack the expression of lineage markers, such as CD3, CD14, CD16, CD19, CD20 and CD56, but express HLA-DR; the plasmacytoid subset displays CD123 (IL-3R), whereas the myeloid one the CD11c and CD33 markers (11) . Also, toll-like receptor (TLR) family is differently expressed in mDCs and pDCs, being TLR7 and nine selectively expressed in pDCs, and TLR1-6, 8, 10 in mDCs (12) .
In addition, mDCs and pDCs have also distinct functions. Plasmacytoid subset produces very high levels of type I IFN-I upon stimulation with viruses, playing a central role in antiviral immunity; thus, they can activate mDCs, induce T cells to produce IFN-c and IL-10, and drive a T h 1 polarization. Moreover, these cells play a role also in peripheral tolerance through generation of regulatory T cells mediated by the up-regulation of inducible T-cell co-stimulator ligand (13) .
mDCs produce large amounts of IL-12, IL-6 and TNF-a upon antigen activation; these cells are potent inducers of T h 1 immune response, but they can also promote, as well as pDCs, T h 2 and T h 0/Tr1 responses, depending on activation signal type (14) .
Previous studies performed on age-related DC changes have shown controversial results (1, (15) (16) (17) (18) (19) . Furthermore, taking account of the limited knowledge on this relevant topic, in this study, we examined the circulating DC number and their subsets throughout the life in a healthy population, in order to provide reference data for comparative studies of several pathological conditions and to contribute to the knowledge of the immunological changes underlying the development of immunosenescence.
Methods

Subjects
Ninety-six clinical healthy subjects were enrolled in this study: 44 males and 52 females, aged from the third day after birth to 74 years, with a mean age 6 standard deviation of 27.57 6 24.12 and 30.18 6 21.58 years, respectively.
Subjects affected by immune system diseases, such as autoinflammatory, rheumatic and congenital immunodeficiency, cancer, viral and/or bacterial infections, hematological diseases, diabetes or treated with immunosuppressive drugs were excluded from the study.
Subjects under 6 months of age were recruited from the Neonatology Unit of our department, among healthy infants who underwent blood sampling. Younger subjects were healthy children, without clinical signs of infections during the preceding 4 weeks or abnormal laboratory parameters indicative of inflammation, whose blood samples were collected during routine examinations. Other volunteers were students and staff of our department.
The study was carried out with the approval of the local Ethical Committee. All the volunteers, or parents for minors, gave informed consent for the inclusion in the study.
Enumeration and phenotypic characterization of PBDCs
Fresh peripheral blood samples were collected from all subjects and analyzed within 24 h. Circulating DCs were enumerated and phenotypically characterized in the two major subsets, mDC and pDC, directly on the whole blood, by three-colors flow cytometric method.
Because of the lack of a specific marker to detect DCs, we used a mixture of monoclonal antibodies, specifically established to identify DCs, purchased by Immunotech (Beckman Coulter Inc.; Brea, CA, USA). Cells were stained with the following antibodies: CD14 and CD16 FITC; CD85k PE; CD33 PC5 or CD123 PC5 (PE linked to cyanine 5) for the mDC and pDC subset, respectively. DCs were identified as CD14 lo/À CD16 Briefly, 100 ll of EDTA anti-coagulated whole blood were incubated with the mixture of monoclonal antibodies for 20 min in the dark at room temperature. Stained aliquots were then incubated for 20 min in the dark at room temperature with Versalyse Solution (Immunotech) to allow the lysis of red cells. The negative control (cells without any monoclonal antibodies) was realized for each sample in order to exclude cell autofluorescence. Cells were washed twice with PBS before being acquired using an EPICS XL-MCL flow cytometry (Beckman Coulter Inc.) with Expo32 Software.
Estimates of absolute numbers of PBDCs were calculated multiplying the percent amount of DCs in the MNCs gate by absolute PBMC count determined using a standard hemacytometer (Abbott Laboratories; Abbott Park, IL, USA).
Enumeration and phenotypic characterization of peripheral blood regulatory T cells
In parallel with the analysis of circulating DC numbers, frequency and absolute number of peripheral blood Treg lymphocytes were determined in 33 healthy subjects, by a four-colors flow cytometric method, in order to investigate a prospective correlation between these two cell populations.
The staining was performed with the following antibodies: FITC-conjugated anti-CD4 (Immunotools GmbH; Friesoythe, Germany); PC5-conjugated anti-CD25; PE-conjugated anti-CD127; energy coupled dye (R-PE Texas Red-X)-conjugated anti-CD45RO (Immunotech).
Circulating Treg cells were identified as CD4 + CD25
+/++ CD127 lo/À cell population, as described (20) (21) (22) . The expression of CD45RO was evaluated in order to estimate the amount of the Treg memory cell population.
The staining procedure was the same as for determining DCs. The acquisition gate was set on lymphocytes on the basis of side scatter and forward scatter characteristics, excluding monocytes (that could express the antigen CD4), granulocytes and debris.
Twenty-five thousands events were acquired for each sample; the negative control (cells without any monoclonal antibodies) was realized for each sample in order to exclude cell autofluorescence.
Estimates of absolute numbers of Treg cells were calculated multiplying the percent amount of Tregs in the lymphocyte gate by absolute lymphocyte count determined using a standard hemacytometer (Abbott Laboratories).
Statistical analysis
Statistical analyses were performed using GraphPad Prism software (GraphPad Software Inc.; La Jolla, CA, USA). Results were expressed as mean 6 SEM. Comparison between age-based groups was determined using the two-tailed Student's t-test for unpaired data. The relationship between absolute number and donor's age was examined using Pearson or Spearman correlation test analysis for parametric or nonparametric data, respectively; all these graphics show the linear or nonlinear regression line (black line) and 95% confidence interval (dotted line). P-values <0.05 were considered statistically significant.
Results
Enumeration of PBDCs
The mean absolute number of total circulating DCs in healthy subjects (n = 96) was 30.42 6 1.61 ll À1 , corresponding to 0.95 6 0.03% of MNCs.
The amount of mDC and pDC was 19.06 6 1.12 ll À1 and 11.34 6 0.65 ll À1 , respectively, corresponding to 0.60 6 0.03% and 0.36 6 0.02% of MNCs.
The DC number decreased with increasing age: a significant inverse correlation was observed between the DC absolute number and the age of the subjects (r = 0.5835, P < 0.0001). Similar results were observed in both the myeloid and plasmacytoid subset when analyzed separately (Fig. 1) . The number of total DCs and of both myeloid and plasmacytoid subsets, expressed as percentage of white blood cells (WBCs), showed a decline among age similar to that one described above (data not shown).
In addition, we analyzed the absolute number of PBDCs in individuals, arbitrarily divided into 20-years age intervals (four groups), in order to highlight possible DC differences between younger and older donor groups. The characteristics of the studied population divided into the different groups are shown in Table 1 . Interestingly, the WBC and MNC numbers were significantly higher in subjects aged 0-19 years than both groups aged 20-39 and 40-59 years; furthermore, a significant difference in the MNC number was also found in the youngest group in comparison to the oldest group aged 60-74 years ( Table 1) .
The total DC number was significantly higher in subjects aged 0-19 years than the other groups. Similar results were obtained when the myeloid and plasmacytoid subsets were considered separately ( Fig. 2 and Table 1 ). Based on these observations, the cutoff age between young and old subjects was set at 20 years for subsequent thorough analysis inside the two main groups.
By using separately the subjects over 20 years (the old group), we observed that only the pDC absolute number significantly decreased with increasing age (r = 0.3061, P < 0.05), whereas the myeloid subset did not show any Fig. 1 . Effects of aging on the absolute number of DCs. Total DC number progressively declined with age, due to the decrease of both mDCs and pDCs. Each symbol represents a single sample. All graphics show the nonlinear regression line (black line) and the 95% confidence interval (dotted lines). mDC, myeloid dendritic cell; pDC, plasmacytoid dendritic cell. age correlation (Fig. 3A) . As shown in Fig. 2(C) , pDC absolute number was significantly lower in subjects aged 60-74 years than that one of the subjects aged 20-39 (6.98 6 0.63 versus 10.44 6 1.01 ll À1 , respectively; P < 0.05), while mDC number did not differ among the three groups. The same analysis performed on total DCs, as absolute values, showed a significant decrease in donors aged 60-74 years compared with those aged 20-39 and 40-59 years old (18.56 6 1.63 versus 24.65 6 1.54 and 24.74 6 1.70 ll À1 , respectively; P < 0.05) (Fig. 2A) .
By analyzing separately the subjects under 20 years (the young group), we found the same results observed in the Results expressed as mean 6 SEM except where otherwise indicated. *P < 0.05: C3 versus A3; B6 versus A6; B7 versus A7; D7 versus B7; C8 versus A8; D8 versus B8 and C8; D9 versus B9 and C9; C10 versus A10. **P < 0.01: B3 versus A3; C5 and D5 versus A5; C6 and D6 versus A6; C7 and D7 versus A7; D8 versus A8; D10 versus A10. ***P < 0.001: D4, C4 and B4 versus A4; B5 versus A5; B9, C9 and D9 versus A9. Fig. 2 . DC absolute number differences among population grouped into four age ranges. (A) The number of total DCs in young subjects (age range 0-19 years) was higher than old ones (age ranges 20-39, 40-59 and 60-74 years), due to higher numbers of both (B) mDCs and (C) pDCs. (A) Subjects aged 60-74 years showed less total DC number than those aged 20-39 years, due to a decrease of the (C) pDC subset, and also than those aged 40-59 years. Each symbol represents a single sample. The black line indicates the mean value. *P < 0.05; **P < 0.01; ***P < 0.001; mDC, myeloid dendritic cell; pDC, plasmacytoid dendritic cell.
old group: the age-related reduction of total DCs was restricted to the plasmacytoid subset (r = 0.3669, P < 0.05), while the myeloid one resulted unaffected by increasing age (Fig. 3B) . The analysis of the same subjects divided into four groups, showed that pDCs were significantly lower in controls aged 10-19 years than those ones aged 0-2 (10.55 6 1.46 versus 19.31 6 3.11, respectively; P < 0.05; data not shown). A further analysis of the whole population, divided into the male (M) and the female (F) groups, showed that total DCs and the myeloid subset were significant lower in the female group than in the male one, whereas pDC number did not differ (Fig. 4A) . These results were not affected by donors' age because we did not observe any significant age difference between male and female groups. Considering the age of 50 years as the cutoff age for pre and postmenopause, we performed the same analysis on the male and female groups further divided into donors under and over 50 years. In this case, we observed that the significant total DC and mDC differences were maintained only in subjects under 50 years, whereas in those ones over 50 years, similar values were found for each subset (Fig. 4B) .
Expression of CD85k on PBDCs
As shown in Fig. 5 , we evaluated the expression level of the surface antigen CD85k both on mDC and pDC; we observed that the mean fluorescence intensity (MFI) on pDCs was significantly higher than that one on mDCs. On the contrary, no correlation was observed between the CD85k MFI and subjects' age both in mDCs and pDCs (data not shown).
Enumeration of peripheral blood Treg lymphocytes
Treg cell enumeration was performed in 34 of 96 subjects analyzed. A significant correlation was found between Treg cell absolute number and donors' age (r = 0.8358, P < 0.05), displaying a drastic decline within the first 10 years of life (Fig. 6A) . The analysis of the subjects arbitrarily divided into four groups of 20-year age intervals, showed that the values of volunteers aged 0-19 were significantly higher than those ones of donors aged 40-59 years (0-19 versus 40-59: 113.00 6 30.51 ll versus 38.30 6 4.94 ll À1 , P < 0.05) and not significantly increased in the elderly (Fig. 6B) .
By analyzing separately the populations under and over 20 years, we observed a significant inverse correlation between the Treg absolute number and volunteers' age in the group under 20 years (r = 0.8441, P < 0.05), whereas donors over 20 years showed a slight increase in the elderly (Fig. 6C and D) . The percentage of CD45RO+ T regulatory cells (Tregs) significantly increased among age (r = 0.8191; P < 0.0001) (Fig. 6E) . Fig. 3 . Effects of aging on the mDC and pDC absolute numbers in young and old subjects. (A and B) Plasmacytoid DC number inversely correlated with age in both subjects under and over 20 years. All graphics show the linear or nonlinear regression line (black lines) and the 95% confidence interval (dotted lines). Each symbol represents a single sample. *P < 0.05; **P < 0.01; ***P < 0.001; mDC, myeloid dendritic cell; pDC, plasmacytoid dendritic cell.
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A significantly positive correlation was found between Treg absolute value and total DC number, as well as the mDC and pDC number (Treg versus total DC: r = 0.5587, P < 0.01; Treg versus mDC: r = 0.5007, P < 0.01; Treg versus pDC: r = 0.5914, P < 0.01) (Fig. 7) .
The absolute number of Tregs did not show any significant correlation with the expression level of the antigen CD85k both on mDCs and pDCs (data not shown).
Discussion
DCs in peripheral blood may be affected by several pathological situations, such as malignancies, in which the loss of DCs is considered one of the major tumor-derived mechanism of immune escape and autoimmune and infectious diseases (23) .
In this study, we investigated the effects of aging on the number of mDC and pDC in a large cohort of healthy subjects, in order to contribute to the knowledge of the biological behavior of these cells throughout the life. Our results showed a significant decline of both mDC and pDC among age, thus affecting the amount of total PBDCs. The comparison among individuals divided into 20-year age intervals (four groups), established 20 years as the cutoff age. In order to deeply investigate the behavior of DCs in the different steps of aging and eliminate the differences between the two extremes (infants and elderly), we performed a separate analysis of the population under and over 20 years old, showing a significant reduction among age only of the pDC subset, whereas the myeloid one remained unaffected.
The DC gating strategy chosen in our experimental approach allowed us to analyze the expression level of the antigen CD85k on these cells, showing no correlation between its expression intensity and subjects' age, but a significantly higher expression on pDCs than mDCs. This result may imply a more predominant involvement of pDCs than mDCs in the induction of immune tolerance, according to previous studies that demonstrate the correlation between immunoglobulin-like transcript 3 expression on DCs and their immunosuppressive activity (24, 25) , suggesting its potential role in the immune dysfunctions.
To our knowledge, this is the first study, which included subjects with a wide and detailed age range, from 3 days after birth to 74 years. In fact, some previous works included either healthy young or adult/elder donors. Concerning the young population under 20 years, our results are in agreement with the literature (26, 27) , whereas there are conflicting results with respect to the aged population, most likely due to different methodological approaches, such as absolute counting method (single versus dual platform assay), Ficoll-density gradient use, flow cytometric gating strategies, the anticoagulant solutions used to collect blood specimens (3, 15, 16, 18, 19) .
Therefore, several papers aimed to standardize an universal DC counting method, focusing the attention on the methodological protocols used rather than on the subjects' age (28) (29) (30) (31) . Other studies examined and compared difference sources of DCs, such as peripheral blood, cord blood and bone marrow (32) (33) (34) .
Concerning the analysis of the differential effects of aging on mDC and pDC cell populations, our results may reflect the different origin of these two subsets; however, several lines of evidence suggest that pDCs can derive from multiple progenitor types, both lymphoid and myeloid, disproving the previous classification of pDC as typically lymphoid DCs (9) . However, pDCs maintain individual developmental pathways, together with phenotype and functions, compared with mDCs. It is also important to note that pDCs are also The decrease of total DC and mDC numbers was maintained only in women under 50 years, whereas comparable levels between female and male individuals were reached over 50 years. Data are shown as mean 6 SEM. *P < 0.05; **P < 0.01; ***P < 0.001; mDC, myeloid dendritic cell; pDC, plasmacytoid dendritic cell. Fig. 5 . Expression of CD85k on mDCs and pDCs. Plasmacytoid DC CD85k expression was significantly higher than that one on myeloid DCs. Data are shown as mean 6 SEM. *P < 0.05; **P < 0.01; ***P < 0.001; mDC, myeloid dendritic cell; pDC, plasmacytoid dendritic cell.
localized in the thymus and in T-cell areas, thus their agerelated decrease could be linked to the physiological wellknown involution of lymphoid tissues, including the thymus, among age (15, 35) .
This observed pDC numerical impairment may help to explain the increased susceptibility to infections and the reduced responsiveness to vaccination of aged people according to the pDC functional defects (in terms of secretion of cytokines and TLR expression) previously demonstrated (15, 16, 36) .
With regard to infants and children under 20 years, the higher numbers of both mDCs and pDCs, observed particularly in the first decade of life, reflect the generous bone marrow activity of this period of life. The high number of pDCs could explain the bias toward T h 2 component of immune responses in newborns (37) and thus the high T h 2 + Tregs positively increased with age. Each symbol represents a single sample. All graphics show the nonlinear regression line (black lines) and the 95% confidence interval (dotted lines). *P < 0.05; **P < 0.01; ***P < 0.001. Treg, T regulatory cell. component of the vaccine response that especially in children develops rapidly and steadily (38) .
The observed differences in the total and mDC numbers between male and female groups led us to further distinguish into each group two sets referring to the menopausal time. In the postmenopausal female set, total DC and mDC values became comparable to those ones of the male set over 50 years. We suppose that this observation can be related to the changes of the immune system caused by the postmenopausal estrogen deprivation, although this is a preliminary result that deserves further investigations. However, recent works investigating the activity of the estrogen on the development and function of immune cells and their progenitors, showed different effects depending on the extracellular cytokine environment and the pattern expression of the immune response genes (39) . Furthermore, the etiological role for sex steroids in both thymus and immune system deterioration with age has been sustained in the recent literature (40) .
CD4+ regulatory T lymphocytes comprise approximately 1-5% of peripheral blood CD4+ T cells (41) . They inhibit proliferation, activation and cytokine secretion of the other immune cells, such as effector T cells and DCs (42) , playing a pivotal role in the maintenance of the peripheral self-tolerance and in the control of tumor immunity.
Our results showed a substantially high number of these cells in the first years of life, followed by a significantly drastic decline which led to a constant value throughout life. The memory component of Treg cell population (CD45RO+ Tregs) significantly increased in aged subjects, as it was to be expected, because of the greater possibility for naive Tregs to have encountered an antigen in elderly people.
The elevated Treg number in infants may be related to the higher Treg amount observed in cord blood with respect adult peripheral blood (43) . The result seems in contrast with the Treg accumulation related to aged hosts, observed in some previous works, that may contribute to the decline of adaptive immune responses in the elderly (44) (45) (46) . However, all these studies enrolled only adult healthy controls, without taking into account children and infants. Furthermore, we observed a slight trend of increment of Treg cells with increasing age, although this result deserves further investigation, being derived from a poor number of cases. Nevertheless, this slight increase coupled with the decline of WBCs in the elderly may confer a major contribution of the Treg cell population toward an immune response.
Interestingly, we also showed a significant direct correlation between Treg absolute value and total DC number, as well as the mDC and pDC number, that is in agreement with the well-known functional relationship between these cell population subsets (47) . Previous studies performed on mice showed a feedback control of Tregs by DCs in vivo: under steady-state conditions, the decrease in Tregs results in an increase of DCs which leads to an increased homeostatic expansion of Tregs, which in turn leads to a return to immune equilibrium (48) . Furthermore, Wang et al. (49) demonstrated that neonatal but not adult CD4+ T cells have an intrinsic 'default' mechanism to become Tregs in response to TCR stimulation.
Conclusively, we believe that this work provides a large set of data of normal reference values of PBDCs in healthy population comprehensive of an extensive and detailed age range, suitable for comparative clinical studies in numerous pathological conditions involving immune and inflammatory disorders. Further investigations focusing on DC distribution in the other peripheral tissues may offer a more detailed physiological picture of these cells. This work may also contribute to the knowledge of the immunological changes underlying the development of immunosenescence.
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